(YI) 111 - Ratings and Ratios

111, Inc. (NASDAQ:YI) operates a comprehensive online and offline healthcare platform in China, integrating retail and wholesale operations across the pharmaceutical and wellness sectors. The company serves both consumers (B2C) and businesses (B2B), offering a diverse range of products including prescription and over-the-counter medications, nutritional supplements, medical devices, and personal care items. Its services extend to online consultations, electronic prescriptions, and an online marketplace for third-party sellers. Additionally, the company provides financial services such as online loan applications and data-driven supply chain solutions. Operating under the Yi Hao Pharmacy brand, it manages physical retail locations in key Chinese cities. Founded in 2010 and headquartered in Shanghai, 111, Inc. rebranded from New Peak Group in 2018, reflecting its expanded scope in the healthcare industry.

Over the next three months, 111, Inc. is expected to experience volatility due to its low average trading volume of 33,847 shares over 20 days. The stock price, currently at $9.01, is above its SMA20 ($7.91) and SMA50 ($6.68) but below the SMA200 ($8.54), indicating potential resistance at higher levels. The ATR of $0.46 suggests moderate price fluctuations. Fundamentally, the companys market cap of $52.15M and negative P/B ratio of -0.69 may signal undervaluation concerns. However, a positive RoE of 9.36% highlights operational efficiency. Investors should monitor these metrics for potential price targets and liquidity impacts.